A detailed history of Collective Family Office LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Collective Family Office LLC holds 1,692 shares of LLY stock, worth $1.3 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
1,692
Previous 1,835 7.79%
Holding current value
$1.3 Million
Previous $1.66 Million 9.75%
% of portfolio
0.41%
Previous 0.49%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $110,416 - $137,282
-143 Reduced 7.79%
1,692 $1.5 Million
Q2 2024

Jul 05, 2024

SELL
$724.87 - $909.04 $17,396 - $21,816
-24 Reduced 1.29%
1,835 $1.66 Million
Q1 2024

Apr 09, 2024

SELL
$592.2 - $792.28 $52,705 - $70,512
-89 Reduced 4.57%
1,859 $1.45 Million
Q4 2023

Jan 09, 2024

SELL
$525.19 - $619.13 $111,865 - $131,874
-213 Reduced 9.86%
1,948 $1.14 Million
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $59,119 - $81,504
-136 Reduced 5.92%
2,161 $1.16 Million
Q2 2023

Jul 12, 2023

SELL
$350.74 - $468.98 $303,039 - $405,198
-864 Reduced 27.33%
2,297 $1.08 Million
Q1 2023

Apr 12, 2023

BUY
$310.63 - $364.82 $530,245 - $622,747
1,707 Added 117.4%
3,161 $1.09 Million
Q4 2022

Jan 11, 2023

SELL
$321.55 - $374.67 $29,904 - $34,844
-93 Reduced 6.01%
1,454 $0
Q3 2022

Oct 14, 2022

SELL
$296.48 - $337.87 $20,753 - $23,650
-70 Reduced 4.33%
1,547 $500,000
Q2 2022

Jul 18, 2022

SELL
$278.73 - $327.27 $15,330 - $17,999
-55 Reduced 3.29%
1,617 $524,000
Q1 2022

Apr 25, 2022

SELL
$234.69 - $291.66 $8,683 - $10,791
-37 Reduced 2.17%
1,672 $479,000
Q3 2021

Oct 08, 2021

SELL
$221.6 - $272.71 $28,364 - $34,906
-128 Reduced 6.97%
1,709 $395,000
Q1 2021

Apr 14, 2021

BUY
$164.32 - $212.72 $20,211 - $26,164
123 Added 7.18%
1,837 $343,000
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $223,608 - $295,887
1,714 New
1,714 $289,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Collective Family Office LLC Portfolio

Follow Collective Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Collective Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Collective Family Office LLC with notifications on news.